Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-25 @ 7:14 PM
Study NCT ID:
NCT00640432
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2008-03-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-10
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-17
First Submit QC Date:
None
Study First Post Date:
2008-03-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-29
Last Update Post Date:
2021-02-02
Last Update Post Date Type:
ACTUAL